Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials

scientific article

Clinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJANTIMICAG.2015.05.012
P698PubMed publication ID26155003
P5875ResearchGate publication ID279965547

P50authorMatteo BassettiQ88607142
P2093author name stringMichele Wible
Jean Li Yan
Paul C McGovern
Christoph Wenisch
Alvaro Quintana
Scott T Rottinghaus
R Daniel Meyer
P433issue3
P304page(s)346-350
P577publication date2015-06-25
P1433published inInternational Journal of Antimicrobial AgentsQ15724616
P1476titleClinical response and mortality in tigecycline complicated intra-abdominal infection and complicated skin and soft-tissue infection trials
P478volume46

Reverse relations

cites work (P2860)
Q60310408A multicenter, double-blind, randomized, comparison study of the efficacy and safety of tigecycline to imipenem/cilastatin to treat complicated intra-abdominal infections in hospitalized subjects in China
Q26739860Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
Q38633450Basis for selecting optimum antibiotic regimens for secondary peritonitis
Q96136650How to manage KPC infections
Q90321474Is fixed short-course antimicrobial therapy justified for patients who are critically ill with intra-abdominal infections?

Search more.